Found: 10
Select item for more details and to access through your institution.
Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor.
- Published in:
- Integrative Cancer Therapies, 2020, v. 19, p. 1, doi. 10.1177/1534735420972486
- By:
- Publication type:
- Article
Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.575457
- By:
- Publication type:
- Article
Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19).
- Published in:
- American Journal of Chinese Medicine, 2020, v. 48, n. 4, p. 763, doi. 10.1142/S0192415X2050038X
- By:
- Publication type:
- Article
Comparison of Immune Checkpoint Inhibitors between Older and Younger Patients with Advanced or Metastatic Lung Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/9853701
- By:
- Publication type:
- Article
Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-58674-4
- By:
- Publication type:
- Article
To be or not to be: whether anti-angiogenic agent combined with immune checkpoint inhibitoris necessary in the treatment of advanced or metastatic renal cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Exploring the Pharmacological Mechanism of the Effective Chinese Medicines Against Gynecological Cancer Based on Meta-Analysis Combined With Network Pharmacology Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.817772
- By:
- Publication type:
- Article
Efficacy and Safety of PARP Inhibitor Combination Therapy in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.638295
- By:
- Publication type:
- Article
Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2018, p. 1, doi. 10.1155/2018/1495768
- By:
- Publication type:
- Article
Transcription factor POU4F2 promotes colorectal cancer cell migration and invasion through hedgehog‐mediated epithelial‐mesenchymal transition.
- Published in:
- Cancer Science, 2021, v. 112, n. 10, p. 4176, doi. 10.1111/cas.15089
- By:
- Publication type:
- Article